User menu

Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity.

Bibliographic reference Marquez, Béatrice ; Pourcelle, Vincent ; Vallet, Coralie M ; Mingeot-Leclercq, Marie-Paule ; Tulkens, Paul M. ; et. al. Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity.. In: Pharmaceutical research, Vol. 31, no.5, p. 1290-301 (2014)
Permanent URL http://hdl.handle.net/2078.1/144345
  1. Van Bambeke F., Michot J.-M., Van Eldere J., Tulkens P.M., Quinolones in 2005: an update, 10.1111/j.1469-0691.2005.01131.x
  2. Michot J.-M., Van Bambeke F., Mingeot-Leclercq M.-P., Tulkens P. M., Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like Transporter, 10.1128/aac.48.7.2673-2682.2004
  3. Seral C., Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus, 10.1093/jac/dkg223
  4. Marquez Beatrice, Van Bambeke Francoise, ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions, 10.2174/138945011795378504
  5. Alvarez Ana I., Pérez Miriam, Prieto Julio G., Molina Antonio J., Real Rebeca, Merino Gracia, Fluoroquinolone Efflux Mediated by ABC Transporters, 10.1002/jps.21233
  6. Merino G., BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) TRANSPORTS FLUOROQUINOLONE ANTIBIOTICS AND AFFECTS THEIR ORAL AVAILABILITY, PHARMACOKINETICS, AND MILK SECRETION, 10.1124/dmd.105.008219
  7. Marquez B., Caceres N. E., Mingeot-Leclercq M.-P., Tulkens P. M., Van Bambeke F., Identification of the Efflux Transporter of the Fluoroquinolone Antibiotic Ciprofloxacin in Murine Macrophages: Studies with Ciprofloxacin-Resistant Cells, 10.1128/aac.01428-08
  8. Marquez Béatrice, Ameye Geneviève, Vallet Coralie M., Tulkens Paul M., Poirel Hélène A., Van Bambeke Françoise, Characterization of Abcc4 Gene Amplification in Stepwise-Selected Mouse J774 Macrophages Resistant to the Topoisomerase II Inhibitor Ciprofloxacin, 10.1371/journal.pone.0028368
  9. Haslam I. S., Wright J. A., O'Reilly D. A., Sherlock D. J., Coleman T., Simmons N. L., Intestinal Ciprofloxacin Efflux: The Role of Breast Cancer Resistance Protein (ABCG2), 10.1124/dmd.111.038323
  10. Michot J.-M., Heremans M. F., Caceres N. E., Mingeot-Leclercq M.-P., Tulkens P. M., Van Bambeke F., Cellular Accumulation and Activity of Quinolones in Ciprofloxacin-Resistant J774 Macrophages, 10.1128/aac.50.5.1689-1695.2006
  11. Lismond A., Tulkens P. M., Mingeot-Leclercq M.-P., Courvalin P., Van Bambeke F., Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected with Listeria monocytogenes: Studies with Ciprofloxacin and Moxifloxacin, 10.1128/aac.00105-08
  12. Vallet Coralie M., Marquez Béatrice, Nhiri Naïma, Anantharajah Ahalieyah, Mingeot-Leclercq Marie-Paule, Tulkens Paul M., Lallemand Jean-Yves, Jacquet Eric, Van Bambeke Françoise, Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin, 10.1016/j.tox.2011.09.003
  13. Beyer R., Pestova E., Millichap J. J., Stosor V., Noskin G. A., Peterson L. R., A Convenient Assay for Estimating the Possible Involvement of Efflux of Fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: Evidence for Diminished Moxifloxacin, Sparfloxacin, and Trovafloxacin Efflux, 10.1128/aac.44.3.798-801.2000
  14. Letafat Bahram, Emami Saeed, Mohammadhosseini Negar, Faramarzi Mohammad Ali, Samadi Nasrin, Shafiee Abbas, Foroumadi Alireza, Synthesis and Antibacterial Activity of New N-[2-(Thiophen-3-yl)ethyl] Piperazinyl Quinolones, 10.1248/cpb.55.894
  15. Pieroni Marco, Dimovska Mirjana, Brincat Jean Pierre, Sabatini Stefano, Carosati Emanuele, Massari Serena, Kaatz Glenn W., Fravolini Arnaldo, From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors ofStaphylococcus aureusMultidrug Efflux Pumps, 10.1021/jm1003304
  16. Martinez Marilyn, McDermott Patrick, Walker Robert, Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals, 10.1016/j.tvjl.2005.07.010
  17. Cormier Ryan, Burda Whittney N., Harrington Lacey, Edlinger Jordan, Kodigepalli Karthik M., Thomas John, Kapolka Rebecca, Roma Glen, Anderson Burt E., Turos Edward, Shaw Lindsey N., Studies on the antimicrobial properties of N-acylated ciprofloxacins, 10.1016/j.bmcl.2012.05.026
  18. Wang Shuo, Jia Xue-Dong, Liu Ming-Liang, Lu Yu, Guo Hui-Yuan, Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety, 10.1016/j.bmcl.2012.07.040
  19. Lemaire S., Tulkens P. M., Van Bambeke F., Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus, 10.1128/aac.01201-10
  20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 2012;22th informational supplement (MS100-S22).
  21. Seral C., Van Bambeke F., Tulkens P. M., Quantitative Analysis of Gentamicin, Azithromycin, Telithromycin, Ciprofloxacin, Moxifloxacin, and Oritavancin (LY333328) Activities against Intracellular Staphylococcus aureus in Mouse J774 Macrophages, 10.1128/aac.47.7.2283-2292.2003
  22. Al-Dgither Saleh, Alvi Syed Naseeruddin, Hammami Muhammad M., Development and validation of an HPLC method for the determination of gatifloxacin stability in human plasma, 10.1016/j.jpba.2005.09.026
  23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.
  24. Michot J.-M., Seral C., Van Bambeke F., Mingeot-Leclercq M.-P., Tulkens P. M., Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages, 10.1128/aac.49.6.2429-2437.2005
  25. Vassault A. Lactate dehydrogenase. In: Bergemeyer HU, editors. Methods in enzymatic analysis. VHC Publishers, Veinheim, Federal Republic of Germany; 1987. p. 118–126.
  26. Renard C, Vanderhaeghe H J, Claes P J, Zenebergh A, Tulkens P M, Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages., 10.1128/aac.31.3.410
  27. Aubert-Tulkens G, Van Hoof F, Tulkens P. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study. Lab Invest. 1979;40(4):481–91.
  28. Petersen U, Grohe K, Kuehle E, Zeiler H-J, Metzger KG. Quinolonecarboxylic acids and antibacterial agents containing these compounds. 17-12-1985;US19840576595 19840203.
  29. Montero M.T., Freixas J., Hernández-Borrell J., Expression of the partition coefficients of a homologous series of 6-fluoroquinolones, 10.1016/s0378-5173(97)04866-7
  30. Kerns Edward H., Di Li, Lipophilicity Methods, Drug-like Properties: Concepts, Structure Design and Methods (2008) ISBN:9780123695208 p.260-270, 10.1016/b978-012369520-8.50024-3
  31. Alovero F, Nieto M, Mazzieri MR, Then R, Manzo RH. Mode of action of sulfanilyl fluoroquinolones. Antimicrob Agents Chemother. 1998;42(6):1495–8.
  32. Takenouchi T, Tabata F, Iwata Y, Hanzawa H, Sugawara M, Ohya S. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother. 1996;40(8):1835–42.
  33. Piddock L. J. V., Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus, 10.1093/jac/47.3.261
  34. Godreuil S., Galimand M., Gerbaud G., Jacquet C., Courvalin P., Efflux Pump Lde Is Associated with Fluoroquinolone Resistance in Listeria monocytogenes, 10.1128/aac.47.2.704-708.2003
  35. Neyfakh A A, Borsch C M, Kaatz G W, Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter., 10.1128/aac.37.1.128
  36. Nikaido Hiroshi, Pagès Jean-Marie, Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria, 10.1111/j.1574-6976.2011.00290.x
  37. Vallet CM, Marquez B, Ngabirano E, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, et al. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages. Int J Antimicrob Agents. 2011;38(3):249–56.
  38. Nikaido H, Thanassi D G, Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples., 10.1128/aac.37.7.1393
  39. Yu Xuanqiang, Zipp Gail L., Davidson III G. W. Ray, 10.1023/a:1018910431216
  40. Luis Vázquez José, Berlanga Mercedes, Merino Sandra, Domènech Òscar, Viñas Miquel, Teresa Montero M., Hernández-Borrell Jordi, Determination by Fluorimetric Titration of the Ionization Constants of Ciprofloxacin in Solution and in the Presence of Liposomes¶, 10.1562/0031-8655(2001)073<0014:dbftot>2.0.co;2
  41. Lizondo Mònica, Pons Miquel, Gallardo Montserrat, Estelrich Joan, Physicochemical properties of enrofloxacin, 10.1016/s0731-7085(96)02033-x
  42. Viswanadhan Vellarkad N., Ghose Arup K., Revankar Ganapathi R., Robins Roland K., Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics, 10.1021/ci00063a006
  43. Klopman Gilles, Li Ju-Yun, Wang Shaomeng, Dimayuga Mario, Computer Automated log P Calculations Based on an Extended Group Contribution Approach, 10.1021/ci00020a009
  44. Ba B. B., Arpin C., Vidaillac C., Chausse A., Saux M.-C., Quentin C., Activity of Gatifloxacin in an In Vitro Pharmacokinetic-Pharmacodynamic Model against Staphylococcus aureus Strains either Susceptible to Ciprofloxacin or Exhibiting Various Levels and Mechanisms of Ciprofloxacin Resistance, 10.1128/aac.01586-05
  45. Ghisalberti Didier, Masi Muriel, Pagès Jean-Marie, Chevalier Jacqueline, Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes, 10.1016/j.bbrc.2005.01.069
  46. Furet Y X, Deshusses J, Pechere J C, Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus., 10.1128/aac.36.11.2506